, the controversial DNA-gathering company that was acquired last August, reported a $27 million loss in the year prior to its sale as net liabilities rose to $67.6 million.
Genuity Science Ireland, which is leading a programme to gather the DNA of one-tenth of the Irish population for private research, was acquired in an all-stock deal by US group, HiberCell, in a transaction that involved theThe company was formally known as WuXi NextCode and had Chinese backing. It bought Dublin-founded Genomics Medicines Ireland in 2015 in a $400 million investment that included participation from Isif.